Postherpetic Neuralgia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Postherpetic Neuralgia Market is segmented By Treatment (Anticonvulsants, Antidepressants, Topical Analgesics, Opioids, Steroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.

Postherpetic Neuralgia Market is segmented By Treatment (Anticonvulsants, Antidepressants, Topical Analgesics, Opioids, Steroids), By Distribution Cha....

Postherpetic Neuralgia Market Size

Market Size in USD

CAGR6.3%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.3%
Market Concentration	Medium
Major Players	Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Teikoku Pharma USA, Astellas Pharma Inc.

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Postherpetic Neuralgia Market Analysis

The postherpetic neuralgia market is estimated to be valued at USD 756.1 Mn in 2024 and is expected to reach USD 1,157.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031. The increasing prevalence of Herpes Zoster infections globally is expected to drive the demand for treatment of postherpetic neuralgia.

Postherpetic Neuralgia Market Report Snapshots

Buy Now